A Clinical Study to Assess the Effect of a Supplement on Digestive Health, Overall Well-being, and Participant Experience.

Amway Corp1 site in 1 country70 target enrollmentNovember 15, 2023

ConditionsDigestive System Disease

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Digestive System Disease
Sponsor: Amway Corp
Enrollment: 70
Locations: 1
Primary Endpoint: Digestive Health Improvement
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The study aims to evaluate the effectiveness of a dietary supplement (greens powder), on improving digestive health, quality of life, energy levels, and satiety over a 14-day period. Participants, aged 18-65 and experiencing mild digestive issues, will consume the greens powder daily and report outcomes through diaries and questionnaires.

Registry

clinicaltrials.gov

Start Date

November 15, 2023

End Date

February 15, 2024

Last Updated

2 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Amway Corp

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Male or female.
•Aged 18-65 years.
•Willing to comply with study requirements.
•No known allergies to the ingredients listed in the product.
•Self-reported mild digestive issues (e.g., occasional bloating, stomach discomfort, occasional constipation, or occasional diarrhea).
•Generally healthy - do not live with any uncontrolled chronic disease .

Exclusion Criteria

•Pre-existing chronic conditions that would prevent adherence to the protocol, including oncological and psychiatric disorders.
•Known severe allergic reactions that require an Epi-Pen.
•Women who are pregnant, breastfeeding, or attempting to conceive.
•History of severe diagnosed digestive disorders (e.g., IBS, IBD, Crohn's disease) or gastrointestinal-tract surgeries.
•Unwillingness to follow the study protocol.
•Invasive medical procedure within the last three weeks or planning one during the study period.
•History of substance abuse.
•Current participation or planning to participate in another research study.
•Regular consumption of probiotics, fiber, or prebiotic supplements within 3 weeks of the study.
•Regular intake of medications that may interfere with the study or study product (e.g., anticoagulants, laxatives, sedatives, beta-blockers, anti-acids) .